Combination antiretroviral therapy (ART) has turned HIV infection into a treatable, chronic condition, rather than one that is almost inevitably fatal. As a result, as they age, people with HIV often begin taking other medications to treat medical conditions ranging from heart disease to gastrointestinal problems to cancer. The increased number of medications creates a risk for drug-drug interactions. Jason Schafer, PharmD, professor and vice chair of pharmacy practice, is exploring combinations of ART drugs that can reduce the number and severity of those interactions.
"Studying HIV Antiretroviral Therapy,"
Thomas Jefferson University Research: Vol. 2
, Article 21.
Available at: https://jdc.jefferson.edu/researchmagazine/vol2/iss1/21